NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

Good point.

I've thought for a long time that Linda cannot go it alone, that they either need to sell outright or partner with BP, because they need the muscle of a larger and connected partner to protect themselves. But it's not the shorts. The biggest risk outside the trial results itself is political risk: that either a large pharma or investor with political connections would undermines the company at the FDA level, which seemed to be happening during the last election cycle when Les was complaining about how difficult it had become to deal with the staff at the FDA.

That's why I think LP will either partner or sell DCVax-L when topline is announced. There is no way that the shorts will allow the price to appreciate significantly from this level if NWBO is still independent and alone. They will do everything they can. They have shown that they can do this before. I know that LP knows this.